Think Surgical yesterday reported a funding round worth $134 million for the robot-assisted orthopedic surgery device it makes.
The Fremont, Calif.-based company’s TSolution One is designed for knee and hip arthroplasties. It’s approved in the U.S. and Europe for total hip procedures; in December 2017 the company won CE Mark approval for a total knee indication and is running a U.S. investigation device exemption study seeking an FDA nod.
In a regulatory filing yesterday Think Surgical said an offering of debt, options, warrants and other securities brought in $134.2 million of its $140 million goal. Six unnamed investors participated, according to the filing.
